Purdue Pharma’s tentative $12B opioid settlement gets pushback


More than two dozen states and territories have agreed to a tentative multibillion-dollar settlement with Purdue Pharma, the maker of OxyContin, for its role in the opioid crisis. At least 16 other state attorneys general, however, told NBC News they won’t agree to the deal. NBC’s Kate Snow reports for TODAY.